INDIANAPOLIS,Oct. 24,2024-- IMG (International Medical Group),an award-winning global insurance benefits and assistance services company,is excited to announce the winners of its eighth annual Leave
-Earnings Webinar Scheduled for 7:00 a.m. ET on November 12,2024-
GUANGZHOU,China,Oct. 22,2024-- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA),a leading game live streaming plat
BEIJING,Oct. 23,2024--A report from People\'s Daily: Chinese President Xi Jinping will attend the 16th BRICS Summit in Kazan,Russia,from Oct. 22 to 24 at the invitation of President of the Russian Fed
KUALA LUMPUR,Malaysia,Oct. 21,2024-- Melbourne Capital Group (MCG) is pleased to announce the appointment of Rob Atherton as Head of International Wealth. Rob\'s appointment is a key step in MCG\'s st
ODENSE,Denmark,Oct. 21,2024--Universal Robots,the Danish collaborative robot (cobot) company,has today presented for the first time the UR AI Accelerator– a ready-to-use hardware and software toolki
SHANGHAI,Oct. 21,2024--The 15th ASU+GSV Summit,a premier international forum for edtech innovation,was recently held in San Diego,California. Centered on drivinginnovation in education and workforce t
In the news release,"SolaX Power Announces 1.498 Billion USD Investment in Energy Storage and Smart Energy Facility",issued on (Oct. 2nd,2024) by SolaX Power over PR Newswire,we are advised
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
